Standard Prostatakrebs

Medikamente bei Prostatakrebs

Unangenehmer Geruch von Urin für Prostata-

Der Urologe. Wenige, unizentrische, retrospektive Daten zur Effektivität der FT Standard Prostatakrebs PCa deuten an, dass Standard Prostatakrebs kurzem Follow-up eine zufriedenstellende Tumorkontrolle bei günstigem Nebenwirkungsprofil zu erreichen ist. Es bestehen Schwächen in der Tumordetektion sowie der histologischen Beurteilung. Eine FT sollte nur im Rahmen von Studien durchgeführt werden. Im Falle einer Progression sollte eine Sekundärbehandlung der Prostata effektiv durchführbar sein.

Patients with low-risk prostate cancer PCa face the difficult decision between a potential overtreatment by one of the standard therapies and Standard Prostatakrebs surveillance AS with the potential insecurity regarding cancer control. A focal therapy FT implies a treatment Standard Prostatakrebs the tumor within the prostate only.

This review evaluates the current literature and expert opinion of different therapies suited for FT as well as concepts for prostate imaging, biopsy and histopathological evaluation. Currently there is a lack of multicenter, randomized, prospective data Standard Prostatakrebs the effectiveness of FT. Nonetheless, the published data indicate a sufficient tumor control with a favorable side effect profile.

There are still flaws in the diagnostics with regard to tumor detection and histological evaluation. Multicenter studies are currently recruiting worldwide which will provide new data with a higher level of evidence.

At present, the effectiveness of FT should not be compared directly to standard radical therapies and FT should only be performed within studies. In cases of cancer progression after FT a salvage treatment should still be possible.

Schostak, U. Witzsch und A. Witzsch ist klinischer Berater der Fa. Galil Medical. Thomas Henkel erhält Vortragshonorare durch die Fa. Die weiteren Autoren geben an, dass keine Interessenskonflikte bestehen. Skip to main content. Advertisement Hide.

Authors Authors and affiliations D. Baumunk A. Blana R. Ganzer T. Henkel J. Köllermann A. Roosen S. Machtens G. Salomon L. Sentker U. Witzsch K. Köhrmann M. Schostak Arbeitsgruppe für Fokale und Mikrotherapie.

Übersichten First Online: 18 October Ergebnisse Wenige, unizentrische, Standard Prostatakrebs Daten zur Effektivität der FT bei PCa deuten an, dass bei kurzem Follow-up eine zufriedenstellende Tumorkontrolle bei günstigem Nebenwirkungsprofil zu erreichen ist.

Focal prostate cancer therapy Capabilities, limitations and prospects. Introduction Patients with low-risk prostate cancer PCa face the difficult decision between a potential overtreatment by one of the standard therapies and active surveillance AS with the potential insecurity regarding cancer control.

Methods This Standard Prostatakrebs evaluates the current literature and expert opinion of Standard Prostatakrebs therapies suited Standard Prostatakrebs FT as well as concepts for prostate imaging, biopsy Standard Prostatakrebs histopathological evaluation. Results Currently there is a lack of multicenter, randomized, prospective data on the effectiveness of FT. Conclusion At present, the effectiveness of FT should not be compared directly to standard radical therapies and FT should only be performed within studies.

This is a preview of subscription content, log in to check access. J Clin Oncol 29 27 — Biological and clinical implications. Cancer Reals 58 1 —28 Google Scholar. Liu W, Laitinen S, Khan S et al Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Eichler K, Hempel S, Wilby J et al Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

Aktualisierung Google Scholar. Barzell WE, Melamed MR Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate — a 4-year experience. Hadaschik BA, Kuru TH, Standard Prostatakrebs C et al A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. Lancet Oncol Epub ahead of print Google Scholar.

Urol Oncol 26 5 Urology 70 6 Suppl :9— Urology 69 6 — Truesdale MD, Cheetham Standard Prostatakrebs, Hruby GW et al An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for Standard Prostatakrebs up.

Eur Urol. BJU Int Suppl 1 :7— Ahmed HU The index lesion and the origin of prostate cancer. Prog Urol 21 4 — Helpap B, Köllermann J Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low-grade prostate cancer. Baumunk 1 Email author A. Blana 2 R. Ganzer 3 T. Henkel 4 Standard Prostatakrebs. Köllermann 5 A. Roosen 6 S. Machtens 7 G. Salomon 8 L. Sentker 9 U. Witzsch 10 K. Köhrmann 11 M.

Schostak 1 Arbeitsgruppe für Fokale und Mikrotherapie 1. Magdeburg Deutschland 2. Klinik für Urologie, Caritas-Krankenhaus St. Josef Universitätsklinikum Standard Prostatakrebs Regensburg Deutschland 4. Institut für ambulante Prostatatherapien Berlin Deutschland 5. Urologische Standard Prostatakrebs Sinsheim Deutschland Personalised recommendations. Cite article How to cite? ENW EndNote. Buy options.